Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Milad Khorramian‑Ghahfarokhi"'
Autor:
Matin Chehelgerdi, Milad Khorramian-Ghahfarokhi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-3 (2024)
Abstract The primary aim of this study is to critically evaluate and comment on the research presented in the article titled “A Novel Super-Enhancer-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer” by Wu et
Externí odkaz:
https://doaj.org/article/f08da9cdf52d4b5f901bc7741dcda330
Autor:
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‑Ghahfarokhi, Marjan Shafieizadeh, Esmaeil Mahmoudi, Fatemeh Eskandari, Mohsen Rashidi, Asghar Arshi, Abbas Mokhtari‑Farsani
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-8 (2024)
Externí odkaz:
https://doaj.org/article/e44903cbf6624612a720eaad420ca3fd
Autor:
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian-Ghahfarokhi, Marjan Shafieizadeh, Esmaeil Mahmoudi, Fatemeh Eskandari, Mohsen Rashidi, Asghar Arshi, Abbas Mokhtari-Farsani
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-45 (2024)
Abstract The CRISPR system is a revolutionary genome editing tool that has the potential to revolutionize the field of cancer research and therapy. The ability to precisely target and edit specific genetic mutations that drive the growth and spread o
Externí odkaz:
https://doaj.org/article/b0a07b646ad7494e99b114c432917022
Autor:
Asghar Arshi, Fatemeh Sadat Sharifi, Milad Khorramian Ghahfarokhi, Zahra Faghih, Abbas Doosti, Sara Ostovari, Elham Mahmoudi Maymand, Mohammad Mahdi Ghahramani Seno
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 12, Iss , Pp 751-757 (2018)
Breast cancer, as the most common cancer in women worldwide, represents about 30% of all cancers affecting women. Long non-coding RNAs (lncRNAs) have been implicated in the regulation of several biological processes, and their dysregulation in cancer
Externí odkaz:
https://doaj.org/article/4e7a2719305c462bbb7264c7ac1cffc9
Autor:
Matin Chehelgerdi, Fatemeh Heidarnia, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, Shahoo Khayati, Milad Khorramian-Ghahfarokhi, Saber Kabiri-Samani, Hamidreza Kabiri
Publikováno v:
Functional & Integrative Genomics. 23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eb0f6c5519356797f70c60bd81da2d6
https://doi.org/10.1007/s10142-023-01031-1
https://doi.org/10.1007/s10142-023-01031-1
Autor:
Mohammad Chehelgerdi, Fereshteh Shojaei, Mehdi Banitalebi-Dehkordi, Milad Khorramian-Ghahfarokhi, Farshad Yazdani-Nafchi
Publikováno v:
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 28(4)
Survivin is one of the most cancer-specific proteins overexpressed in almost all malignancies, but is nearly undetectable in most normal tissues in adults. Functionally, as a member of the inhibitor of apoptosis family, survivin has been shown to inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452fdb8920718230273a854e92b835f0
https://pubmed.ncbi.nlm.nih.gov/29847456
https://pubmed.ncbi.nlm.nih.gov/29847456
Autor:
Kianoush Dormiani, Mohammad Hossein Nasr-Esfahani, Milad Khorramian Ghahfarokhi, Ali Mohammadi, Farnoosh Jafarpour
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
Integration target site is the most important factor in successful production of transgenic animals. However, stable expression of transgene without disturbing the function of the host genome depends on promoter methylation, transgene copy number and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73a6e4022e5994f7a2663570814ecf51
http://europepmc.org/articles/PMC5684190
http://europepmc.org/articles/PMC5684190